Heparin therapy for sudden sensorineural hearing loss.
Twenty-three patients with sudden unilateral sensorineural hearing loss were treated with a course of intravenous heparin sodium within one week of the onset of the hearing loss. Complete or good recovery developed in a total of 69.6% of these patients, but this is very similar to previously reported criteria of 66% spontaneous recovery. There was one complication in the series, ie. priapism.
D005260:Female; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D003639:Hearing Loss, Sudden / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male
D006493:Heparin